Cargando…

Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer—A population‐based cohort study

BACKGROUND: The rate of primary and secondary treatment while on active surveillance (AS) for localized prostate cancer at the general population level is unknown. Our objective was to determine the patterns of secondary treatments after primary surgery or radiation for patients who undergo AS. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matta, Rano, Hird, Amanda E., Dvorani, Erind, Saskin, Refik, Nason, Gregory J., Kulkarni, Girish, Kodama, Ronald T., Herschorn, Sender, Nam, Robert K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541139/ https://www.ncbi.nlm.nih.gov/pubmed/32757442 http://dx.doi.org/10.1002/cam4.3341

Ejemplares similares

Assessment of Secondary Sarcomas Among Patients With Cancer of the Abdomen or Pelvis Who Received Combinations of Surgery, Radiation, and Chemotherapy vs Surgery Alone
por: Hird, Amanda E., et al.
Publicado: (2020)

Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada
por: Matta, Rano, et al.
Publicado: (2019)

Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada
por: Hird, Amanda E, et al.
Publicado: (2021)

The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation
por: Wallis, Christopher J. D., et al.
Publicado: (2018)

Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer
por: Wallis, C J D, et al.
Publicado: (2015)

Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision Analysis
por: Wallis, Christopher J. D., et al.
Publicado: (2017)

Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
por: Wallis, Christopher J D, et al.
Publicado: (2016)

NIRS: Past, Present, and Future in Functional Urology
por: Koven, Alexander, et al.
Publicado: (2022)

Prospective Long-term Health-related Quality of Life Outcomes After Surgery, Radiotherapy, or Active Surveillance for Localized Prostate Cancer
por: Kord, Eyal, et al.
Publicado: (2022)

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
por: Mukherjee, Subhabrata, et al.
Publicado: (2021)

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
por: Ahlberg, Mats S., et al.
Publicado: (2023)

A Feasibility Study of the Therapeutic Response and Durability of Short-term Androgen-targeted Therapy in Early Prostate Cancer Managed with Surveillance: The Therapeutics in Active Prostate Surveillance (TAPS01) Study
por: Barrett, Tristan, et al.
Publicado: (2022)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Increasing research capacity with ICES Data & Analytic Services (DAS)
por: Ishiguro, Lisa, et al.
Publicado: (2017)

Prostate cancer surveillance by occupation and industry: the Canadian Census Health and Environment Cohort (CanCHEC)
por: Sritharan, Jeavana, et al.
Publicado: (2018)

Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance
por: Magnani, Christopher J., et al.
Publicado: (2020)

Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis
por: Alpert, Evgenia, et al.
Publicado: (2021)

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
por: Olivier, Jonathan, et al.
Publicado: (2022)

Low-acuity emergency department use among patients in different primary care models in Hamilton and Ontario
por: Ly, Olivia, et al.
Publicado: (2021)

Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
por: Aerts, Jan, et al.
Publicado: (2023)

Trends in active surveillance for very low‐risk prostate cancer: do guidelines influence modern practice?
por: Parikh, Rahul R., et al.
Publicado: (2017)

Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative
por: Remmers, Sebastiaan, et al.
Publicado: (2022)

Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance
por: Nilsson, Rasmus, et al.
Publicado: (2021)

Prospective Implementation and Early Outcomes of a Risk-stratified Prostate Cancer Active Surveillance Follow-up Protocol
por: Thankapannair, Vineetha, et al.
Publicado: (2023)

Barriers to obtaining prostate multi‐parametric magnetic resonance imaging in African‐American men on active surveillance for prostate cancer
por: Walton, Eric L., et al.
Publicado: (2019)

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
por: Häggström, Christel, et al.
Publicado: (2014)

Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
por: Beckmann, Kerri, et al.
Publicado: (2021)

What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine
por: Wagg, Adrian S., et al.
Publicado: (2021)

Institute for Clinical Evaluative Sciences (ICES) Exploratory Data & Analytic Services Private Sector Pilot Project
por: Schull, Michael, et al.
Publicado: (2017)

Comparison of biopsy under‐sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies
por: Li, Weiyu, et al.
Publicado: (2020)

Five-Year Prospective Observational Study of African-American Men on Active Surveillance for Prostate Cancer Demonstrates Race Is Not Predictive of Oncologic Outcomes
por: Pincus, Joshua, et al.
Publicado: (2022)

Associations of multimorbidity and patient‐reported experiences of care with conservative management among elderly patients with localized prostate cancer
por: Fiano, Ryan M., et al.
Publicado: (2020)

Radical cystectomy—what is the optimal surgical approach?
por: Nason, Gregory J., et al.
Publicado: (2020)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Pooled solifenacin overactive bladder trial data: Creation, validation and analysis of an integrated database
por: Chapple, Christopher R., et al.
Publicado: (2016)

A population-based study of the extent of colorectal cancer screening in men with HIV
por: Antoniou, Tony, et al.
Publicado: (2015)

Revisiting the roles of cAMP signalling in the progression of prostate cancer
por: Parsons, Emma C., et al.
Publicado: (2023)

The Value of Phenotypic Precision Medicine in Prostate Cancer
por: Hawkey, Nathan M, et al.
Publicado: (2022)

A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer
por: Kulkarni, Girish S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ujmk1ohlpnsd4i2i73fmfrve2